fingolimod hydrochloride and Central Retinal Edema, Cystoid
fingolimod hydrochloride has been researched along with Central Retinal Edema, Cystoid in 31 studies
Research
Studies (31)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.23) | 29.6817 |
2010's | 24 (77.42) | 24.3611 |
2020's | 6 (19.35) | 2.80 |
Authors
Authors | Studies |
---|---|
Asahi, M; Culp, C; Foos, WF; Patronas, M | 1 |
Andersen, CU; Hilt, C; Nørgaard, TL | 1 |
Goh, LY; Harvey, JP; Jackson, TL; Kirthi, V; Silber, E | 1 |
Bisecco, A; Capuano, R; d'Ambrosio, A; Filippi, M; Gallo, A; Gesualdo, C; Lanza, M; Leocani, L; Maimone, D; Marino, C; Rodegher, M; Rossi, S; Simonelli, F; Tedeschi, G | 1 |
Karakosta, C; Kourentis, C | 1 |
Gillam, M; Richardson, T | 1 |
Aslam, T; Jasani, KM; Rog, D; Sharaf, N | 1 |
Dick, HB; Elling, M; Kakkassery, V; Kleiter, I; Rehrmann, J; Schelenz, D; Schöllhammer, J | 1 |
Annunziata, P; Capozzoli, M; Fruschelli, M; Gelmi, MC; Masi, G | 1 |
Collins, W; Francis, G; Jager, RD; Jampol, LM; Reder, AT; Tang, D; Zarbin, MA; Zhang, X | 1 |
Chang, A; Chui, J; Herkes, GK | 1 |
Almeida, DR; Belliveau, MJ; Dorrepaal, SJ; Gale, JS; Minuk, A | 1 |
Georgakopoulos, CD; Georgalas, I; Makri, OE | 1 |
Asensio-Sánchez, VM; Ramoa-Osorio, R; Trujillo-Guzmán, L | 1 |
Francis, CE | 1 |
Chen, C; Cugati, S; Lee, A; Thoo, S | 1 |
Coote, M; Gaskin, JC | 1 |
Aktas, O; Finis, D; Geerling, G; Guthoff, R; Harmel, J; Hartung, HP; Ringelstein, M; Schröder, K | 1 |
Saida, K; Ueda, N | 1 |
Akamatsu, M; Akiyama, H; Hara, D; Hasegawa, Y; Ogura, H; Shinohara, K; Suzuki, Y | 1 |
Brescia Morra, V; Brogi, D; Comi, G; Guidi, L; Laroni, A; Lugaresi, A; Mancardi, GL; Pozzilli, C; Raimondi, D; Turrini, R; Uccelli, A | 1 |
Cifuentes-Canorea, P; Nieves-Moreno, M; Sáenz-Francés, F; Santos-Bueso, E | 1 |
Frank, B; Osmanovic, A; Pars, K; Pielen, A; Pul, R; Schmalstieg, H; Schwenkenbecher, P; Skripuletz, T; Stangel, M; Sühs, KW; Yildiz, Ö | 1 |
Agoropoulou, C; Burtin, P; Calabresi, P; Hohlfeld, R; Kappos, L; Leyk, M; O'Connor, P; Polman, C; Radue, EW; Selmaj, K; Zhang-Auberson, L | 1 |
Weinstock-Guttman, B; Yeh, EA | 1 |
Bryan, JS; Turaka, K | 1 |
Bhatti, MT; Jain, N | 1 |
Bermel, RA; Cohen, JA; Hara-Cleaver, C; Ontaneda, D; Rudick, RA | 1 |
Huggins, A; Sergott, RC | 1 |
Afshar, AR; Fernandes, JK; Hariprasad, SM; Ksiazek, SM; Patel, RD; Reder, AT; Sheth, VS | 1 |
Almony, A; Blinder, KJ; Brennan, DC; Saab, G; Schuessler, R | 1 |
Reviews
5 review(s) available for fingolimod hydrochloride and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Fingolimod-associated macular edema: A case report of late onset.
Topics: Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Tomography, Optical Coherence; Visual Acuity | 2022 |
Drug-induced macular edema.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Fingolimod Hydrochloride; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Interferons; Macular Edema; Niacin; Ophthalmic Solutions; Propylene Glycols; Sphingosine; Tamoxifen; Taxoids; Thiazolidinediones; Timolol | 2013 |
Visual issues in multiple sclerosis.
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Neuromyelitis Optica; Nystagmus, Pathologic; Ocular Motility Disorders; Optic Neuritis; Prognosis; Propylene Glycols; Sphingosine; Uveitis | 2013 |
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.
Topics: Activities of Daily Living; Administration, Oral; Bradycardia; Central Nervous System; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Progression; Female; Fingolimod Hydrochloride; Herpesviridae Infections; Humans; Immunosuppressive Agents; Macular Edema; Male; Multiple Sclerosis, Relapsing-Remitting; Neuroimmunomodulation; Neurologic Examination; Propylene Glycols; Receptors, Lysosphingolipid; Recurrence; Sphingosine; Treatment Outcome; Young Adult | 2011 |
Fingolimod-associated macular edema: incidence, detection, and management.
Topics: Fingolimod Hydrochloride; Humans; Macular Edema; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine | 2012 |
Trials
4 trial(s) available for fingolimod hydrochloride and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Topics: Adolescent; Adult; Double-Blind Method; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Ophthalmoscopy; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2013 |
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Topics: Adult; Female; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Infections; Italy; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome | 2017 |
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Topics: Administration, Oral; Adolescent; Adult; Arrhythmias, Cardiac; Brain; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Fingolimod Hydrochloride; Herpesviridae Infections; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Liver Function Tests; Macular Edema; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Young Adult | 2010 |
Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
Topics: Cyclosporine; Drug Therapy, Combination; Fingolimod Hydrochloride; Fluorescein Angiography; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Macular Edema; Prednisone; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Transplantation, Homologous | 2008 |
Other Studies
22 other study(ies) available for fingolimod hydrochloride and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Fingolimod Hydrochloride; Fluoresceins; Humans; Macular Edema; Visual Acuity | 2022 |
Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Macula Lutea; Macular Edema; Male; Multiple Sclerosis; Retina; Tomography, Optical Coherence; Visual Acuity | 2020 |
Real-world incidence of fingolimod-associated macular oedema.
Topics: Adult; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Incidence; London; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tomography, Optical Coherence | 2020 |
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod.
Topics: Fingolimod Hydrochloride; Humans; Macular Edema; Multiple Sclerosis; Tomography, Optical Coherence; Visual Acuity | 2021 |
Bilateral fingolimod-associated macular oedema development after cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Fingolimod Hydrochloride; Humans; Macular Edema | 2021 |
Fingolimod-associated macular oedema.
Topics: Anti-Inflammatory Agents; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Prednisolone; Tomography, Optical Coherence | 2017 |
[Early onset of fingolimod-associated macular edema].
Topics: Female; Fingolimod Hydrochloride; Germany; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting | 2018 |
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
Topics: Adult; Analysis of Variance; Female; Fingolimod Hydrochloride; Fovea Centralis; Humans; Immunosuppressive Agents; Macula Lutea; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tomography, Optical Coherence | 2019 |
Management of fingolimod-associated macular edema.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Ketorolac Tromethamine; Macular Edema; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2013 |
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Topics: Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone | 2013 |
[Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Propylene Glycols; Sphingosine | 2014 |
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Topics: Aged; Anti-Inflammatory Agents; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis; Triamcinolone | 2015 |
Postoperative cystoid macular oedema in a patient on fingolimod.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Ophthalmic Solutions; Prednisolone | 2015 |
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
Topics: Acetazolamide; Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis, Relapsing-Remitting; Optic Neuritis; Visual Acuity; Young Adult | 2015 |
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Topics: Adult; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Male; Multiple Sclerosis; Retinal Hemorrhage; Tomography, Optical Coherence | 2015 |
Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.
Topics: Aged; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis, Relapsing-Remitting | 2016 |
Early and recurrent macular oedema in a patient treated with fingolimod.
Topics: Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tomography, Optical Coherence | 2019 |
Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?
Topics: Adult; Clinical Trials as Topic; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Multiple Sclerosis; Tomography, Optical Coherence | 2016 |
Does fingolimod in multiple sclerosis patients cause macular edema?
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence | 2012 |
Early tolerability and safety of fingolimod in clinical practice.
Topics: Adult; Bradycardia; Chest Pain; Drug Substitution; Female; Fingolimod Hydrochloride; Headache; Humans; Hypertension; Lymphopenia; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nausea; Patient Acceptance of Health Care; Product Surveillance, Postmarketing; Propylene Glycols; Retrospective Studies; Sphingosine | 2012 |
Gilenya safety update: cardiac and macula.
Topics: Bradycardia; Drug Monitoring; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Propylene Glycols; Sphingosine | 2012 |
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Topics: Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Retrospective Studies; Sphingosine; Tomography, Optical Coherence; Visual Acuity | 2013 |